Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Cancer Surgery
Removal of liver cancer
What removal of liver cancer entails, how surgical liver resection works, what clinical evidence shows regarding survival and recurrence, how partial hepatectomy compares with ablation and transplantation, approximate costs in Turkey against the UK, US and Germany, realistic before-and-after expectations from imaging, recovery milestones, risks, and how to evaluate a specialised hepatobiliary surgical centre.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Cancer Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Removal of Liver Cancer
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Removal of liver cancer in Turkey: what it is and how it works
Removal of liver cancer, surgically termed partial hepatectomy or liver resection, removes malignant tumours while preserving sufficient healthy tissue for normal liver function. The liver filters toxins, produces clotting proteins, and secretes bile. Crucially, it possesses a unique capacity to regenerate, allowing surgeons to excise diseased segments knowing the remaining liver will regrow functional volume within weeks.
Resection treats primary liver cancers, such as hepatocellular carcinoma and cholangiocarcinoma, and secondary tumours from the bowel. Patients with metastatic spread following removal of colon cancer frequently undergo liver resection when metastases are confined to the liver. Turkish specialist hospitals offer open and minimally invasive resections evaluated by multidisciplinary tumour boards. This guide explains surgical mechanisms, clinical evidence, costs, recovery, and hospital quality standards. For other cancer procedures, see our guide to oncology treatments in Turkey.
How does surgical liver resection remove tumours?
The liver is divided into eight independent functional segments under the Couinaud classification. Each segment has its own portal vein and hepatic artery blood supply, bile duct drainage, and venous outflow. This anatomy allows a surgeon to remove an isolated segment (segmentectomy), a lobe (hemihepatectomy), or a wedge containing the tumour without compromising blood flow to the rest of the organ.
Before surgery, surgeons use triphasic CT and dynamic contrast MRI to evaluate tumour margins and calculate future liver remnant (FLR) volume. If the remnant is too small, interventional radiologists perform portal vein embolisation (PVE) to redirect blood flow, stimulating healthy tissue to enlarge over four to six weeks before surgery. During resection, intraoperative ultrasound (IOUS) placed directly on the liver identifies vascular relationships and guides precise cutting margins.
Does removal of liver cancer work: what does clinical evidence show?
Clinical guidelines from the European Association for the Study of the Liver (EASL), European Society for Medical Oncology (ESMO), and the NHS confirm that surgical resection is the primary curative-intent treatment for resectable liver tumours. Achieving clear microscopic margins (an R0 resection) provides the highest likelihood of long-term disease-free survival.
For solitary hepatocellular carcinoma with preserved liver function, studies report five-year survival rates between 50% and 70%. For resectable colorectal liver metastases, complete surgical resection combined with chemotherapy achieves five-year survival rates between 40% and 55%. Evidence is strongest when treatment is coordinated by a multidisciplinary team.
However, surgery does not cure underlying cirrhosis or hepatitis. Tumour recurrence occurs in 50% to 70% of hepatocellular carcinoma patients within five years, from microscopic spread or new lesions developing in diseased tissue. Resection is an essential component of cancer treatment rather than an absolute guarantee, requiring lifelong structured surveillance.
Removal of liver cancer cost in Turkey compared with the UK, US and Germany
The figures below are approximate package ranges for liver resection surgery, not binding quotes. Pricing varies with the anatomical extent of resection, surgical approach, and intensive care requirements. Each hospital confirms pricing in a written quotation following scan review.
| Country | Approximate cost range |
|---|---|
| Turkey | €12,000 – €28,000 |
| United Kingdom | €25,000 – €55,000 |
| United States | €45,000 – €120,000 |
| Germany | €22,000 – €48,000 |
Several clinical factors influence the removal of liver cancer cost. A minor wedge resection requires less theatre time than an extended right hepatectomy. In Turkey, packages generally include pre-operative imaging review, surgeon and anaesthetist fees, theatre charges, surgical intensive care (ICU) monitoring, hospital accommodation, pathology, routine medications, and airport transfers. You can request a detailed evaluation through our free quote service.
Surgical resection, radiofrequency ablation or liver transplantation?
Patients often compare surgical resection with thermal ablation, liver transplantation, or transarterial chemoembolisation (TACE). The best approach depends on tumour dimensions, nodule count, liver health, and general fitness.
| Method | Best suited to | Typical limits |
|---|---|---|
| Partial hepatectomy (resection) | Solitary or oligometastatic tumours with preserved liver function | Requires adequate future liver remnant; limited by severe cirrhosis |
| Thermal ablation (RFA/MWA) | Small tumours under 3 cm away from major vessels | Higher recurrence in larger lesions; heat-sink effect near blood vessels |
| Liver transplantation | Early tumours within Milan criteria with decompensated cirrhosis | Donor organ shortages, waiting lists, and lifelong immunosuppression |
| TACE / chemoembolisation | Intermediate multifocal tumours confined to the liver | Palliative intent; rarely produces complete long-term clearance |
As in other organ-sparing oncology procedures such as a lumpectomy, obtaining clear margins (R0 resection) is crucial to minimise local recurrence. Where background liver function permits, surgical resection remains the standard recommendation for larger tumours because it removes malignant tissue entirely and provides tissue for detailed pathology.
Who is an eligible candidate, and who is not?
Candidacy depends on balancing oncological clearance against the risk of post-operative liver failure. An appropriate candidate must have resectable tumours, sufficient future liver remnant, and stable background liver function.
Good candidates typically present with:
- A solitary lesion or localized oligometastatic tumours resectable with clear microscopic margins.
- Preserved liver function classified as Child-Pugh class A, with normal bilirubin and no portal hypertension.
- Anticipated future liver remnant of at least 20% to 25% in normal liver, or 30% to 40% with fibrosis or prior chemotherapy.
- Good performance status (ECOG 0 or 1) and cardiopulmonary reserve to undergo major general anaesthesia.
Patients who are not suitable include those with decompensated cirrhosis (Child-Pugh B or C, ascites, or jaundice), widespread bilobar tumours leaving inadequate remnant tissue, main portal vein tumour invasion, or uncontrolled extrahepatic metastases. In these circumstances, multidisciplinary teams recommend systemic therapies, immunotherapy, chemoembolisation, or supportive care.
What happens during the operation step by step?
Liver resection is performed under general anaesthesia with specialized cardiovascular monitoring, lasting between two and six hours depending on resection complexity.
The procedure follows structured surgical stages:
- Anaesthesia and vascular control: Anaesthetists maintain low central venous pressure to minimise bleeding during liver division. Continuous arterial monitoring is maintained.
- Surgical access: Surgeons access the liver through a subcostal laparotomy incision or via laparoscopic ports for accessible peripheral tumours.
- Intraoperative ultrasound: Direct ultrasound maps tumours against hepatic veins and portal branches, confirming safe parenchymal margins.
- Vascular isolation: Inflow vessels to the affected segments are isolated. Surgeons may apply temporary inflow clamping (Pringle manoeuvre) to control bleeding during transection.
- Parenchymal transection: Liver tissue is divided using ultrasonic aspirators (CUSA) or bipolar devices, preserving vessels and bile ducts for precise clipping or stapling.
- Haemostasis and drainage: The resection bed is checked for bleeding and bile leakage. A closed suction drain is placed, and incisions are closed in layers.
Before and after surgery: what scans and histology show
In liver cancer surgery, evaluating removal of liver cancer before and after relies entirely on objective cross-sectional imaging, laboratory tumour markers, and histopathology rather than aesthetic photographs.
Before surgery, multiphase CT or MRI scans determine tumour size, vascular relationships, and future liver remnant volume. Baseline blood tests document tumour markers, such as alpha-fetoprotein (AFP) for hepatocellular carcinoma or carcinoembryonic antigen (CEA) for bowel metastases, alongside liver biochemistry and clotting profiles.
After surgery, histological analysis of the resected specimen verifies tumour classification, cellular differentiation, vascular invasion, and surgical margin status. An R0 margin confirms complete microscopic clearance. Post-operative CT or MRI scans at one to three months confirm absence of residual disease and show compensatory hypertrophy, as the remaining liver expands to restore functional mass.
Your hospital stay in Turkey and recovery timeline
International patients travelling for removal of liver cancer in Turkey should plan for a stay of fourteen to twenty-one days to cover pre-operative assessment, surgery, inpatient recovery, and post-discharge checks.
The recovery process progresses through defined stages:
- Hospital stay (Days 1 to 7): Patients spend twenty-four hours in the intensive care unit for close monitoring before moving to a surgical ward. Early mobilization and breathing exercises start on day one to reduce chest and clotting complications.
- Pain and drain management: Pain is controlled with patient-controlled analgesia or epidural infusions, transitioning to oral analgesics around day three. The abdominal drain is removed once fluid output is minimal and clear, usually by day five to seven.
- Hotel convalescence (Days 8 to 14): Patients rest in hotel accommodation, attending outpatient reviews for wound checks, suture removal, and blood tests confirming stable liver enzymes and clotting.
- Flying home and long-term healing: Fit-to-fly clearance is granted once independent mobility and wound healing are confirmed. Desk work resumes after four to six weeks, while full physical recovery and liver regeneration take eight to twelve weeks.
Potential risks and post-hepatectomy complications
Partial hepatectomy is major surgery carrying specific clinical risks. Authoritative organisations including the British Association for the Study of the Liver (BASL), EASL, and the NHS highlight that treatment in high-volume hepatobiliary units significantly lowers complication rates.
Recognised surgical complications include:
- Post-hepatectomy liver failure (PHLF): Transient or severe impairment of liver function, characterised by hyperbilirubinemia, coagulopathy, and ascites. Pre-operative volumetric remnant calculations are essential to prevent this.
- Bile leakage: Fluid collection from divided microscopic bile ducts on the cut liver surface. Many leaks resolve with drainage, while persistent leaks may require temporary endoscopic stenting (ERCP).
- Haemorrhage: Bleeding from the liver parenchyma or major vascular pedicles, occasionally requiring blood transfusion or surgical re-exploration.
- Pleural effusion: Fluid accumulation above the right diaphragm following upper abdominal manipulation, managed with breathing exercises and early mobilization.
- Thromboembolism: Deep vein thrombosis and pulmonary embolism, prevented with prophylactic blood thinners, compression stockings, and pneumatic boots.
How to evaluate a hepatobiliary hospital, and questions to ask
When researching hospitals for liver cancer surgery, verifying surgical expertise and hospital infrastructure is essential. Patients should prioritize dedicated hepatopancreatobiliary (HPB) surgical units with high annual case volumes, which clinical evidence associates with lower complication rates.
Key quality benchmarks include:
- Multidisciplinary tumour board (MDT): HPB surgeons, oncologists, radiologists, and hepatologists jointly reviewing scans to determine optimal treatment.
- On-site surgical ICU: A dedicated 24/7 intensivist-led unit equipped to manage complex hepatic recovery.
- Advanced technology: Availability of intraoperative ultrasound, ultrasonic aspirators (CUSA), and minimally invasive platforms.
- Accreditation: International hospital certification from bodies such as Joint Commission International (JCI).
Questions to ask your surgical team:
- Has my case been evaluated by a multidisciplinary liver tumour board?
- What is my future liver remnant volume, and is portal vein embolisation required?
- Is the planned resection open, laparoscopic, or robotic?
- What is your centre's specific incidence of liver failure and bile leaks?
- How will records be transferred to my oncologists at home?
Red flags include claims of absolute cancer cures, operating without multidisciplinary review, facilities lacking an on-site surgical ICU, and pressure to commit before scans are examined. You can read more about how it works before sending medical records, and submit your recent CT or MRI discs through our free quote service for multidisciplinary review.
Conditions treated with Removal of Liver Cancer
Hospitals with Oncology in Turkey
Frequently asked questions
Removal of liver cancer, known surgically as partial hepatectomy or liver resection, involves removing the cancerous tumour along with a healthy margin of surrounding liver tissue. Because the liver can regenerate its functional mass, surgeons can safely excise single or multiple segments while preserving vital blood supply and bile ducts to maintain normal hepatic function.
Surgical removal is the primary curative-intent treatment for resectable primary liver cancer and colorectal metastases. When clear microscopic margins are achieved, five-year survival ranges from 40% to 70% in selected patients. However, underlying liver disease or microscopic spread can lead to recurrence, making regular post-operative surveillance scans and blood tests essential.
Removal of liver cancer in Turkey typically ranges from €12,000 to €28,000, depending on whether the resection is minor or major, the surgical technique, and intensive care requirements. In the UK, private treatment often costs €25,000 to €55,000, while US prices can exceed €100,000. Turkish hospitals confirm individual prices through written quotes.
Hospital recovery usually takes five to eight days, including one day in intensive care. Patients generally spend two to three weeks in Turkey before flying home. Light activities can resume after three to four weeks, while full physical recovery and liver regeneration typically take eight to twelve weeks, depending on the resection extent.
Surgical resection removes the tumour entirely, provides tissue for detailed pathology, and offers the highest long-term disease-free survival for larger tumours. Thermal ablation destroys tumours using heat and is less invasive, but it is generally reserved for small lesions under three centimetres or patients whose general health rules out major abdominal surgery.
Yes. The liver possesses a unique capacity for cellular regeneration. Remaining healthy liver cells enlarge and multiply rapidly, typically restoring up to eighty or ninety per cent of the original functional liver volume within six to twelve weeks after surgery, provided the remaining liver tissue is not severely cirrhotic or damaged by chemotherapy.
Before surgery, multiphase CT or MRI scans map tumour dimensions, vascular contact, and future liver remnant volume. After surgery, follow-up cross-sectional imaging at one to three months confirms the complete excision of tumours, demonstrates healthy regeneration of the remnant liver parenchyma, and verifies the absence of residual or recurrent malignant tissue.
Liver surgery is a major operation, but pain is carefully managed using modern anaesthetic protocols such as epidural analgesia, patient-controlled intravenous analgesia, and local nerve blocks. Most patients experience surgical soreness and wound discomfort that gradually decreases over the first two weeks, transitioning to oral pain medications before hospital discharge.
Potential complications include post-hepatectomy liver failure, bile leakage from the cut liver surface, intra-abdominal bleeding, pleural effusion, and wound infection. International guidelines emphasise having liver surgery performed at high-volume hepatobiliary centres equipped with dedicated surgical intensive care units and multidisciplinary teams to manage these complex risks effectively.
Patients should plan for a total stay of fourteen to twenty-one days in Turkey. This includes pre-operative imaging and multidisciplinary review, five to eight nights in hospital, and a week of post-discharge monitoring in local accommodation to ensure blood tests, liver function, and surgical wound healing are stable before travelling home.
Patient stories